





OMitral valve surgery for functional mitral regurgitation: Should
moderate to severe tricuspid regurgitation be treated? Apropensity score
analysis
Andrew S. Wechsler, MDAny study designed to examine tricuspid valve intervention
in patients with functional tricuspid valve regurgitation
(FTR) associated with functional mitral valve regurgitation
(FMR) begins with the understanding that FMR in this set-
ting is different from FMR associated with structural mitral
valve disease. Operations for structural mitral valve disease
are anticipated to correct most of the abnormal physiologic
characteristics associated with the volume overload of mitral
regurgitation and to promote progressive and durable
reverse remodeling. It is thus reasonable to intuit that mild
degrees of FTR in this setting are likely to regress or remain
the same as pulmonary artery pressures, right ventricular
dimensions and function, and left ventricular properties
improve with time.
Such is not the case for FMR associated with abnormal
left ventricular systolic function. FMR can be surgically cor-
rected with low operative mortality. However, there remains
a high recurrence rate, particularly when severe FMR is
treated by isolated valve repair rather than replacement.1
The early changes of reverse left ventricular remodeling
are not necessarily sustained, and the progressive nature of
the intrinsic cardiomyopathy (ischemic or dilated) com-
monly resumes after an initial period of improvement.2,3 A
study from the Mayo Clinic found a clear correlation be-
tween the extent of functional mitral regurgitation and late
mortality. Wu and colleagues,4 however, reported no benefit
in longevity for patients undergoing operation for FMR in
association with either ischemic or dilated cardiomyopathy.
Pending further understanding through additional studies,
correction of FMR may be thought of as setting back the ad-
verse physiologic clock for a while but not stopping it from
running.
Calafiore and colleagues5 used propensity matching to
study a group of patients with FTR secondary to FMR. Al-
most all patients who had severe FTR underwent repair
with a DeVega annuloplasty. Patients with mild to moderate
FMR who did not have repair had decreased longevity and
poorer survival in a low New York Heart Association func-
tional class (ie, closer to class I). It was particularly interest-
ing that patients with uncorrected mild to moderate FTR in
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doi:10.1016/j.jtcvs.2008.07.019The Journal of Thoracic and Cthis population fared less well than patients with surgically
corrected severe FTR. It is tempting to assume that impaired
long-term outcome was related to recurrence of FMR, but
a small study by Matsunaga and Duran6 dissociated dimin-
ished prognosis and return of FTR from return of FMR.
The intimation is that, after repair of FMR, progression of in-
trinsic left ventricular chamber disease is a more important
predictor of long-term outcome than is return of mitral regur-
gitation. This hypothesis could be tested by serially studying
a cohort of patients who underwent chordal-sparing mitral
valve replacement rather than repair for FMR.
Propensity matches balance populations for variables that
are measured and included in the match. They do not balance
for variables not included that may contain important infor-
mation. In the cohort of patients studied by Calafiore and
colleagues,5 there was great similarity among the patients,
such that 100 of 110 patients were matched for the variables
selected. The data are presented by degree of FTR before,
early, and late after operation. Surgeons who treat patients
with FTR require additional information to help individual-
ize their treatment choices and to further enhance under-
standing of the disease processes. Specifically, a surgeon
should know which variables predict mortality in the pa-
tients who underwent operation and the patients who expe-
rienced recurrent FTR. This information is particularly
important for the variables that were not matched, such as
details of right ventricular performance and chamber dimen-
sion beyond the tricuspid annular plane systolic excursion,
which was measured as a rough indicator of right ventricular
function.
Because multiple descriptors of left ventricular perfor-
mance were included in the propensity match, one might
hypothesize that the critical information determining long-
term functional class and survival were related to properties
of the right ventricle that were not described. This concept
was indirectly substantiated in a recent study by de Bonis
and colleagues.7 In their study, patients with tricuspid regur-
gitation grades less than 3þgenerally did not have corrected
at the time of operation for FMR. During a 2-year interval,
conditions in approximately 18% of these patients pro-
gressed 2 grades. Preoperative right ventricular function
was shown to be an important predictor of worsening tricus-
pid regurgitation, but no attempt at correlation to late mortal-
ity was made.5 However, a study by Nath and colleagues,8
which corrected for differences in ventricular function and
pulmonary artery pressure, demonstrated that worsening
degrees of tricuspid regurgitation were associated with









FMR ¼ functional mitral valve regurgitation
FTR ¼ functional tricuspid valve regurgitation
Propensity matching is a powerful tool that can create
‘‘matched’’ subjects, a logit that defines closely related sub-
jects for the variables proposed or a number that can be used
in a multivariable analysis. The technique is most effective
in large populations when many variables are studied be-
cause it yields greater confidence that the patients included
are similar and differ only in the particular variable of inter-
est. In smaller studies with more similar populations, it may
have been of interest to use traditional multivariable logistic
regression analysis on the entire population to determine
whether other variables might have had an important effect.
This is particularly true for the interaction between ischemic
cardiomyopathy and the lesser likelihood of tricuspid valve
repair in that population and the potential for a different
long-term outcome between ischemic and idiopathic cardio-
myopathy, independent from the tricuspid valve repair. One
would like to be certain that it was failure to address the
moderate FTR that was the critical factor in survival rather
than the underlying condition that created the FMR.
A potential confounding factor in the study by Calafiore
and colleagues5 may relate to quantification of tricuspid re-
gurgitation. The extent of tricuspid regurgitation seen on the
echocardiogram is variable over time and heavily dependent
on the loading condition of both ventricles when the studies
are performed. The inclusion of patients designated as hav-
ing mild to moderate FTR in the unrepaired group who may
have had moderate or severe FTR could have had some ef-
fect on the outcome data. Standardization of the extent of tri-
cuspid regurgitation is extremely difficult, so much so that268 The Journal of Thoracic and Cardiovascular SuDreyfus and colleagues9 reported a series of patients in
whom the decision to repair or not repair the tricuspid valve
was made on an anatomic basis (annular dilation) rather than
a functional basis.
This study is an important addition to our information
base about FMR in the setting of ischemic mitral regurgita-
tion. As Calafiore and colleagues5 make clear, the decision
to perform a tricuspid procedure when performing a mitral
procedure is not terribly difficult. Tricuspid repairs can be
performed with minimal to no additional myocardial ische-
mic time, are inherently simple, and have little risk of
additional operative morbidity while potentially conferring
long-term benefit, as demonstrated in this report.
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